Dr. David Eagle: The Hospital Squeeze

Dr. David Eagle, president of the American Independent Medical Practice Association and a hematologist-oncologist, joins host Joe Grogan to examine the decline of independent oncology practices in America. The episode documents a dramatic shift: independent practices provided 85% of cancer care in 2000 but now deliver only roughly 45%, with hospital consolidation as the primary driver. Eagle explains the mechanics of this squeeze through several policy and business mechanisms. Hospitals use aggressive acquisition strategies and create artificial competition by establishing practices near independents. Once acquired, hospitals exploit facility fees—charging patients higher copays while billing separately for facility use—a practice that disadvantages independent competitors. The 2003 Medicare Modernization Act shifted reimbursement from Average Wholesale Price to Average Selling Price, squeezing independent practice margins. The 340B drug pricing program, which allows hospitals to purchase drugs at steep discounts, creates what Eagle calls an 'uneven playing field' that independent practices cannot access. Recent policy changes under the Inflation Reduction Act and the 2025 physician fee schedule further accelerate the crisis by shrinking add-on payments as negotiated drug prices fall. Eagle argues policymakers undervalue independent community oncologists despite their importance to the healthcare system. The episode also touches on promising cancer treatment advances—CAR T cell therapy, personalized vaccines, and precision medicine—with Eagle warning these innovations may be lost if community-based oncology practices disappear. A brief mention notes Jeff Faserka, CEO of New York Cancer and Blood (which acquired Eagle's practice), was previously considered for FDA commissioner. The episode frames hospital consolidation as a 15-year 340B-driven acquisition strategy with serious consequences for patient care delivery and medical innovation.

Verdict: A substantive, well-structured policy conversation that delivers on its title and explains real mechanisms of healthcare consolidation, but lacks sourcing rigor and opposing perspectives needed for full credibility.

Government rubric

• Accuracy and sourcing 3/5 20%

  Key statistics (85% to 45% decline) and policy mechanisms (ASP system, 340B, IRA) are cited but without primary source documentation visible in show notes; relies on guest expertise rather than documented evidence.

• Balance and context 2/5 20%

  Episode presents hospital consolidation as clearly harmful through one expert's lens; lacks hospital system perspective, counterarguments about consolidation benefits, or acknowledgment of competing policy rationales.

• Clarity on what it means 3/5 15%

  Explains specific policy mechanisms (facility fees, 340B discounts, ASP reimbursement) and their impact on practice viability, but real-world consequences for patient outcomes or care quality remain somewhat abstract.

• Substance 4/5 15%

  Dense with policy detail, specific mechanisms, and timeline; includes treatment innovation discussion; some padding in guest introduction and CEO tangent, but mostly substantive content throughout.

• Delivers on its title 5/5 15%

  Title 'The Hospital Squeeze' is fully delivered: episode systematically explains how hospitals squeeze independent practices through consolidation, reimbursement policy, and 340B advantages.

• Value for time 4/5 15%

  40 minutes covers substantial policy ground with clear structure and timestamps; pacing appears reasonable, though the brief cancer treatment innovation section (36:40+) feels somewhat disconnected from main narrative.

How we score Government

Worth it if you care about healthcare policy, independent medicine, oncology practice economics, or how consolidation affects care delivery—but not if you need balanced debate or primary-source documentation.

Based on the episode description. AI-generated; it can be wrong.